James Samuel Shannon - 13 Jun 2024 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Julia Walcott, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
3
Filing time
17 Jun 2024, 16:11:25 UTC
Previous filing
17 May 2024
Next filing
16 May 2025

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney